Aura Biosciences, Inc. announced that it will receive $80,483,829 in funding on March 17, 2021. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.34 USD | +2.51% | +1.94% | -17.16% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.16% | 355M | |
+64.92% | 62.59B | |
-1.85% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.05% | 26.21B | |
-21.96% | 19.09B | |
+4.21% | 13.08B | |
+25.74% | 12.26B | |
+27.42% | 12.05B |
- Stock Market
- Equities
- AURA Stock
- News Aura Biosciences, Inc.
- Aura Biosciences, Inc. announced that it expects to receive $80.483829 million in funding